Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 940.00p on 04-12-2025 at 16:40:00
Change 30.00p 3.3%
Buy 934.00p
Sell 930.00p
Last Trade: Buy 2,850.00 at 940.00p
Day's Volume: 84,626
Last Close: 940.00p
Open: 912.00p
ISIN: GB0004559349
Day's Range 910.00p - 940.00p
52wk Range: 480.00p - 974.00p
Market Capitalisation: £299.89m
VWAP: 921.31408p
Shares in Issue: 31.90m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 2,850 940.00p Suspected BUY Trade
16:35:06 - 04-Dec-25
Buy* 323 932.2137p Ordinary
16:28:59 - 04-Dec-25
Sell* 75 932.00p Automatic Execution
16:18:32 - 04-Dec-25
Sell* 324 932.00p Automatic Execution
16:18:32 - 04-Dec-25
Buy* 1,676 931.257p Suspected BUY Trade
16:07:59 - 04-Dec-25
Buy* 96 934.00p Automatic Execution
15:48:25 - 04-Dec-25
Buy* 76 934.00p Automatic Execution
15:46:50 - 04-Dec-25
Sell* 4,535 929.56p Negotiated Trade
15:43:47 - 04-Dec-25
Buy* 134 930.00p Automatic Execution
15:41:30 - 04-Dec-25
Buy* 255 930.00p Automatic Execution
15:34:00 - 04-Dec-25
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Dec 2025 (Thu) 912.00 940.00 910.00 940.00 84,626
3rd Dec 2025 (Wed) 910.00 914.00 890.00 910.00 114,691
2nd Dec 2025 (Tue) 930.00 930.00 916.00 924.00 79,478
1st Dec 2025 (Mon) 950.00 952.00 932.00 932.00 61,270
28th Nov 2025 (Fri) 970.00 974.00 950.00 952.00 139,182
27th Nov 2025 (Thu) 938.00 968.00 938.00 964.00 157,971
26th Nov 2025 (Wed) 920.00 942.00 920.00 940.00 118,212
25th Nov 2025 (Tue) 902.00 928.00 900.00 914.00 180,136
24th Nov 2025 (Mon) 892.00 912.00 890.00 912.00 81,696
21st Nov 2025 (Fri) 892.00 892.00 874.00 884.00 136,276
20th Nov 2025 (Thu) 900.00 914.00 900.00 908.00 66,283
19th Nov 2025 (Wed) 908.00 912.00 894.00 894.00 245,652
18th Nov 2025 (Tue) 884.00 914.00 884.00 908.00 198,948
17th Nov 2025 (Mon) 894.00 900.00 888.00 890.00 54,136
14th Nov 2025 (Fri) 866.00 896.00 856.00 896.00 108,224
13th Nov 2025 (Thu) 890.00 890.00 872.00 872.00 59,318
12th Nov 2025 (Wed) 866.00 890.00 866.00 882.00 124,902
11th Nov 2025 (Tue) 860.00 860.00 844.00 858.00 103,174
10th Nov 2025 (Mon) 826.00 850.00 826.00 850.00 127,839
7th Nov 2025 (Fri) 844.00 846.00 812.00 812.00 239,847
6th Nov 2025 (Thu) 840.00 840.00 832.00 840.00 439,766
5th Nov 2025 (Wed) 840.00 840.00 824.00 826.00 106,750
4th Nov 2025 (Tue) 840.00 842.00 834.00 834.00 308,834
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
3rd Dec 2025 11:52 am RNS Net Asset Value(s)
2nd Dec 2025 11:41 am RNS Net Asset Value(s)
1st Dec 2025 12:00 pm RNS Net Asset Value(s)
28th Nov 2025 5:19 pm RNS Total Voting Rights
28th Nov 2025 11:58 am RNS Net Asset Value(s)
27th Nov 2025 11:42 am RNS Net Asset Value(s)
26th Nov 2025 11:42 am RNS Net Asset Value(s)
26th Nov 2025 7:00 am RNS Transaction in Own Shares
25th Nov 2025 11:48 am RNS Net Asset Value(s)
24th Nov 2025 11:47 am RNS Net Asset Value(s)
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

International Biotechnology beats benchmark with 0.7% NAV gain

6th Nov 2025 19:17

(Alliance News) - International Biotechnology Trust PLC on Thursday said its portfolio continued to outperform the sector benchmark as the company reported full-year results. Read More

IN BRIEF: International Biotechnology Trust notes Novo to buy Akero

9th Oct 2025 15:40

International Biotechnology Trust PLC - investor in biotech and life science companies - Notes portfolio firm Akero Therapeutics Inc as agreed to be taken over by Novo Nordisk AS in a deal worth up to EUR5.2 billion. Novo Nordisk will pay an initial USD54 per share, with a contingent portion of the deal worth USD6 per share. The Bagsvaerd, Denmark-based pharmaceuticals company will pay an initial EUR4.7 billion to buy the firm, and a potential additional payment of EUR500 million, hinging on US regulatory approval for key Akero treatment Efruxifermin. The deal adds Akero's Efruxifermin to Novo Nordisk's portfolio. The asset is aimed at treating metabolic dysfunction-associated steatohepatitis, a disease caused by fat buildup in the liver. Read More

International Biotechnology to raise unquoted exposure with Schroders

2nd Oct 2025 13:31

(Alliance News) - International Biotechnology Trust PLC on Thursday said it has partnered with Schroders Capital to access more investees in the earlier stages of development. Read More

UK dividends calendar - next 7 days

15th Aug 2025 16:46

Read More

UK dividends calendar - next 7 days

17th Jul 2025 14:22

Read More

See more Int.biotech. news
FTSE 100 Latest
Value9,710.87
Change18.80

Login to your account

Forgot Password?

Not Registered